²²⁵Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic

The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of ¹⁷⁷Lu-radiolabeled somatostatin analogs. These radiopharmaceuticals have especially improved progression-free survival...

全面介绍

书目详细资料

Principais autores:	Léa Rubira, Emmanuel Deshayes, Lore Santoro, Pierre Olivier Kotzki, Cyril Fersing
格式:	Artigo
语言:	Inglês
出版:	MDPI AG 2023-03-01
丛编:	Pharmaceutics
主题:	actinium-225 radionuclide production radiolabeling targeted radionuclide therapy targeted alpha-therapy radiobiology
在线阅读:	https://www.mdpi.com/1999-4923/15/4/1051
标签:	添加标签 没有标签, 成为第一个标记此记录!